2025 MIPS Top Proposed Changes Report, Including Quality Measures
The Centers for Medicare and Medicaid Services (CMS) released the 2025 Quality Payment Program (QPP) proposed rule. The 2,248-page proposed rule contained many changes that we summarize in our recent article on Navigating the 2025 QPP Proposed Rule.
In this article, we provide an overview of the MIPS Quality measures that have proposed changes which are detailed in our Top 2025 MIPS Proposed Changes Report.
Dermatology
Five dermatology measures are subject to proposals for 2025 MIPS. For details, see our Top 2025 MIPS Proposed Changes Report.
Removal
- Measure 137: Melanoma: Continuity of Care – Recall System
Modification
- Measure 176: Tuberculosis Screening Prior to First Course of Biologic and/or Immune Response Modifier Therapy
- Measure 485: Psoriasis- Improvement in Patient-Reported Itch Severity
- Measure 486: Dermatitis- Improvement in Patient-Reported Itch Severity
New for 2025
- Melanoma: Tracking and Evaluation of Recurrence
Ophthalmology
Seven ophthalmology measures are subject to proposals for 2025 MIPS. For details, see our Top 2025 MIPS Proposed Changes Report.
Removal
- Measure 19 (MIPS CQM only): Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care
- Measure 137: Melanoma: Continuity of Care – Recall System
Modification
- Measure 117: Diabetes: Eye Exam
- Measure 384: Adult Primary Rhegmatogenous Retinal Detachment Surgery: No Return to the Operating Room Within 90 Days of Surgery
- Measure 500: Acute posterior vitreous detachment appropriate examination and follow-up
- Measure 501: Acute posterior vitreous detachment and acute vitreous hemorrhage appropriate examination and follow-up
Orthopedic Surgery
Six orthopedic surgery measures are subject to proposals for 2025 MIPS. For details, see our Top 2025 MIPS Proposed Changes Report.
Modification
- Measure 178: Rheumatoid Arthritis (RA): Functional Status Assessment
- Measure 180: Rheumatoid Arthritis (RA): Glucocorticoid Management
- Measure 182: Functional Outcome Assessment
- Measure 322: Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Preoperative Evaluation in Low-Risk Surgery Patients
- Measure 376: Functional Status Assessment for Total Hip Replacement
- Measure 418: Osteoporosis Management in Women Who Had a Fracture
- Measure 470: Functional Status After Primary Total Knee Replacement
Otolaryngology
Three otolaryngology measures are subject to proposals for 2025 MIPS. For details, see our Top 2025 MIPS Proposed Changes Report.
Modification
- Measure 277: Sleep Apnea: Severity Assessment at Initial Diagnosis
- Measure 331: Adult Sinusitis: Antibiotic Prescribed for Acute Viral Sinusitis (Overuse)
- Measure 464: Otitis Media with Effusion: Systemic Antimicrobials – Avoidance of Inappropriate Use
Physical Therapy/Occupational Therapy
Six physical therapy and occupational therapy measures are subject to proposals for 2025 MIPS. For details, see our Top 2025 MIPS Proposed Changes Report.
Modification
- Measure 182*: Functional Outcome Assessment
- Measure 281*: Dementia: Cognitive Assessment
- Measure 282: Dementia: Functional Status Assessment
- Measure 286*: Dementia: Safety Concern Screening and Follow-Up for Patients with Dementia
- Measure 288*: Dementia: Education and Support of Caregivers for Patients with Dementia
- Measure 291*: Assessment of Cognitive Impairment or Dysfunction for Patients with Parkinson’s Disease
*included in the PT/OT MIPS Specialty measure set
Podiatry
One podiatry measure is subject to a proposal for 2025 MIPS. For details, see our Top 2025 MIPS Proposed Changes Report.
Modification
- Measure 418: Osteoporosis Management in Women Who Had a Fracture
Generally Applicable Measures
14 generally applicable measures (one of which is surgery-specific) are subject to proposals for 2025 MIPS. For details, see our Top 2025 MIPS Proposed Changes Report.
Removal
- Measure 155 (CLAIMS only): Falls: Plan of Care
Modification
- Measure 1: Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%)
- Measure 130: Documentation of Current Medications in the Medical Record
- Measure 181: Elder Maltreatment Screen and Follow-Up Plan
- Measure 182: Functional Outcome Assessment
- Measure 236: Controlling High Blood Pressure
- Measure 238: Use of High-Risk Medications in Older Adults
- Measure 317: Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented
- Measure 322: Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Preoperative Evaluation in Low-Risk Surgery Patients [surgical measure]
- Measure 374: Closing the Referral Loop: Receipt of Specialist Report
- Measure 493: Adult Immunization Status
- Measure 498: Connection to Community Service Provider
- Measure 503: Gains in Patient Activation Measure (PAM) Scores at 12 Months
New
- Adult COVID-19 Vaccination Status
Next Steps
- Check out our Top 2025 MIPS Proposed Changes Report.
- Share this information with your colleagues.
- Check back in coming weeks to see an analysis of some of the new and modified MIPS Value Pathways (MVPs), an explanation of the proposals on alternative payment models (APMs), opportunities to have your voice heard, and more!
- Subscribe to our blog to get alerts on this and other important issues. You can subscribe using the field in our website footer below.
- If you are an Anatomy IT client, contact your MIPS Expert if you have any questions.
- If you are not an Anatomy IT client, contact us to learn more about our MIPS Success Plan and to reap the rewards of our combined decades of experience.
If you have any questions on this, let us know!
